March 22, 2016
Drugmaker Valeant CEO leaving as investor Ackman joins the board
Drugmaker Valeant Pharmaceuticals International Inc said on Monday its chief executive officer is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business.